These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 453559)

  • 1. 4-Aminopyridine potentiates neostigmine and pyridostigmine in man.
    Miller RD; Booij LH; Agoston S; Crul JF
    Anesthesiology; 1979 May; 50(5):416-20. PubMed ID: 453559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of Org NC 45 neuromuscular blockade by neostigmine, pyridostigmine, and 4-aminopyridine.
    Booij LH; van der Pol F; Crul JF; Miller RD
    Anesth Analg; 1980 Jan; 59(1):31-4. PubMed ID: 7188663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of neostigmine and pyridostigmine by 4-aminopyridine in the rat.
    Miller RD; Dennissen PA; van der Pol F; Agoston S; Booij LH; Crul JF
    J Pharm Pharmacol; 1978 Nov; 30(11):699-702. PubMed ID: 31433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium.
    Ferguson A; Egerszegi P; Bevan DR
    Anesthesiology; 1980 Nov; 53(5):390-4. PubMed ID: 7425377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of d-tubocurarine- and pancuronium-induced neuromuscular blockades by pyridostigmine in man.
    Fogdall RP; Miller RD
    Anesthesiology; 1973 Nov; 39(5):504-9. PubMed ID: 4355635
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonism of pancuronium- and pipecuronium-induced neuromuscular block.
    Gyermek L; Cantley EM; Lee C
    Br J Anaesth; 1995 Apr; 74(4):410-4. PubMed ID: 7734260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.
    Cronnelly R; Morris RB; Miller RD
    Anesthesiology; 1982 Oct; 57(4):261-6. PubMed ID: 7125261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridostigmine as an antagonist of d-tubocurarine-induced and pancuronium-induced neuromuscular blockade.
    Ravin MB
    Anesth Analg; 1975; 54(3):317-21. PubMed ID: 1169015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolites of neostigmine and pyridostigmine do not contribute to antagonism of neuromuscular blockade in the dog.
    Hennis PJ; Cronnelly R; Sharma M; Fisher DM; Miller RD
    Anesthesiology; 1984 Nov; 61(5):534-9. PubMed ID: 6149707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade.
    Donati F; Lahoud J; McCready D; Bevan DR
    Can J Anaesth; 1987 Nov; 34(6):589-93. PubMed ID: 3677283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
    Donati F; Ferguson A; Bevan DR
    Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on muscarinic receptors of various agents in reversal of neuro-muscular blockade: a study evaluating atropine, glycopyrron, neostigmine and pyridostigmine.
    Eriksen S; Hansen EK; Hasselstrøm L
    Acta Anaesthesiol Scand; 1978; 22(4):447-57. PubMed ID: 726861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blockade.
    Neigh JL
    Surg Clin North Am; 1975 Aug; 55(4):837-50. PubMed ID: 241125
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine.
    Donati F; McCarroll SM; Antzaka C; McCready D; Bevan DR
    Anesthesiology; 1987 Apr; 66(4):471-6. PubMed ID: 3565812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atropine-neostigmine mixture: a dose-response study.
    Naguib M; Gomaa M
    Can J Anaesth; 1989 Jul; 36(4):412-7. PubMed ID: 2758540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancuronium-induced neuromuscular blockade, and its antagonism by neostigmine, at 29, 37, and 41 c.
    Miller RD; Roderick LL
    Anesthesiology; 1977 May; 46(5):333-5. PubMed ID: 851242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of pancuronium and its metabolites by neostigmine in cats.
    Booij LH; Miller RD; Jones MJ; Stanski DR
    Anesth Analg; 1979; 58(6):483-6. PubMed ID: 574733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect on heart rate of neuromuscular blockade reversal by pyridostigmine.
    Long G; Marsh HM
    Anaesth Intensive Care; 1981 May; 9(2):144-6. PubMed ID: 7258611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neostigmine and 4-aminopyridine antagonism of lincomycin-pancuronium neuromuscular blockade in man.
    Booij LH; Miller RD; Crul JF
    Anesth Analg; 1978; 57(3):316-21. PubMed ID: 566050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between d-tubocurarine, pancuronium, polymyxin B, and neostigmine on neuromuscular function.
    Van Nyhuis LS; Miller RD; Fogdall RP
    Anesth Analg; 1976; 55(2):224-8. PubMed ID: 176904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.